Imapextide is a glucagon-like peptide-1 ( GLP-1 ) receptor antagonist that can be used in hypoglycemia research [1].
References:
[1]. WHO. International Nonproprietary Names for Pharmaceutical Substances (INN), Proposed International Nonproprietary Names: List 132. WHO Drug Information, Vol. 38, No. 4, 2024.
References:
[1]. WHO. International Nonproprietary Names for Pharmaceutical Substances (INN), Proposed International Nonproprietary Names: List 132. WHO Drug Information, Vol. 38, No. 4, 2024.
















